---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-22-012368"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:17:58.562587+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tonix Pharmaceuticals increases authorized common shares from 150M to 1B

## Summary
- Shareholders approved amendment to increase authorized common stock from 150,000,000 to 1,000,000,000 shares.
- Vote totals: 242,748,061 for, 46,849,004 against, 746,889 abstentions.
- Series A preferred stock (10 votes/share) and Series B (2,500 votes/share) cast in favor or mirrored common vote.
- Special meeting held December 13, 2022; record date October 28, 2022.

## SEC filing metadata
- accession: 0001387131-22-012368
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000138713122012368/0001387131-22-012368-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000138713122012368/tnxp-8k_121322.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-22-012368
- JSON: https://secwatch.observer/filing/0001387131-22-012368.json
- Plain text: https://secwatch.observer/filing/0001387131-22-012368.txt

## Key facts
- Governance Changes
  Tonix Pharmaceuticals Holding Corp.: Increased authorized common stock from 150,000,000 to 1,000,000,000 shares (effective 2022-12-13).
  - Change: charter amendment
  - Effective: 2022-12-13
  source text: Tonix Pharmaceuticals Holding Corp. (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to increase the number of authorized shares of the Company’s common stock from 150,000,000 to 1,000,000,000 shares (the “Charter Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713122012368/0001387131-22-012368-index.htm
- Shareholder Votes
  Tonix Pharmaceuticals Holding Corp. shareholders approved Adjournment of the Special Meeting to solicit additional proxies if necessary.
  - Outcome: passed
  source text: Proposal 2 The Company’s shareholders approved a proposal for the adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes to approve Proposal 1, as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 20,060,382 5,967,057 316,516 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713122012368/0001387131-22-012368-index.htm
- Shareholder Votes
  Tonix Pharmaceuticals Holding Corp. shareholders approved Amendment to Articles of Incorporation to increase authorized shares of common stock from 150,000,000 to 1,000,000,000.
  - Proposal: charter amendment
  - Outcome: passed
  source text: Proposal 1 The Company’s shareholders approved an amendment to the Company’s Articles of Incorporation, as amended, to increase the Company’s authorized shares of common stock from 150,000,000 to 1,000,000,000, as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 242,748,061 46,849,004 746,889 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713122012368/0001387131-22-012368-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.